National Hospital Organization - Osaka General Hospital

Site:	National Hospital Organization - Osaka General Hospital
Address:
City:	Osaka
State:
Zip:	540-0006
Country:	Japan

Phase [desc]	Trial	Trial Status	Site Status	Drug	NCT#
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785